Inveni Capital


Inveni Capital offers entrepreneurial venture capital to life science companies in Northern and Central Europe.

Inveni Capital, established in 2007, is a life science focused venture capital firm with €30 million under management. Inveni Capital invests in early to growth stage pharmaceutical development and medical technology companies in Northern and Central Europe.

Inveni Capital has offices in Helsinki, Finland and Munich, Germany. 
 

 

 





















 

 

News

Monday, 18 January 2010

Boehringer Ingelheim and Priaxon announc

Boehringer Ingelheim and Priaxon announce a collaboration to research and develop novel treatments for ...

Read More...

Friday, 17 April 2009

Inveni Capital invests in miacom Diagnos

Inveni Capital invests in miacom ...

Read More...

Wednesday, 1 April 2009

Inveni Capital invests in Onbone (ex Inj

Inveni Capital invests in Onbone (ex ...

Read More...